|
BAT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60790000003352E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04859999999307E-05 |
| Normal-vs-Stage2 |
9.516900E-03 |
| Normal-vs-Stage3 |
3.776200E-04 |
| Normal-vs-Stage4 |
2.28410000002732E-06 |
| Stage1-vs-Stage2 |
8.426200E-01 |
| Stage1-vs-Stage3 |
8.592600E-01 |
| Stage1-vs-Stage4 |
1.190230E-01 |
| Stage2-vs-Stage3 |
9.465800E-01 |
| Stage2-vs-Stage4 |
2.061600E-01 |
| Stage3-vs-Stage4 |
1.466190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.52080000002253E-07 |
| Normal-vs-AfricanAmerican |
7.29359999951384E-07 |
| Normal-vs-Asian |
6.22040000000101E-05 |
| Caucasian-vs-AfricanAmerican |
6.884200E-02 |
| Caucasian-vs-Asian |
5.655600E-01 |
| AfricanAmerican-vs-Asian |
1.815780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.045200E-04 |
| Normal-vs-Female |
1.77950000002092E-06 |
| Male-vs-Female |
6.652800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.56698999999039E-05 |
| Normal-vs-Age(41-60Yrs) |
7.64460000000078E-05 |
| Normal-vs-Age(61-80Yrs) |
6.959100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.920100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.932400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.443000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.948800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.490400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.184000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.530600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.855590E-01 |
| Classical-VS-Follicular |
3.38979999625622E-08 |
| Classical-VS-Other |
2.987800E-02 |
| Classical-VS-Normal |
8.79200046099982E-10 |
| Tall-VS-Follicular |
2.181500E-02 |
| Tall-VS-Other |
1.480040E-01 |
| Tall-VS-Normal |
4.183700E-03 |
| Follicular-VS-Other |
9.964600E-01 |
| Follicular-VS-Normal |
9.755800E-01 |
| Other-VS-Normal |
9.917800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.996700E-04 |
| Normal-vs-N1 |
9.828900E-04 |
| N0-vs-N1 |
4.317200E-01 |
|
|
